Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Public Health

Influenza in children

Erica Weir
CMAJ November 11, 2003 169 (10) 1052;
Erica Weir
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Background and epidemiology: The US Advisory Committee on Immunization Practices now recommends influenza immunization of all healthy children aged 6–23 months.1 This is a change from its previous recommendations, which focused on vaccinating children with chronic medical conditions, and differs from current Canadian guidelines, which encourage vaccinating healthy young children but do not designate them as being at high risk of infection.2 The change in the US guidelines resulted from recent reports indicating that otherwise healthy young children aged 6–23 months were being admitted to hospital because of influenza and its complications at rates comparable to those among people at high risk, for whom routine immunization was recommended, such as elderly people.3 One study reported an influenza-related rate of hospital admission among healthy children under 2 years of age that was 12 times higher than the rate among healthy children aged 5–17 years and that approached the rate among children 5–17 years with chronic health conditions.4

In the middle of the influenza season last year, the problem of influenza in children attracted attention when, in January 2003, the Michigan Department of Community Health received reports of severe influenza-associated morbidity and mortality among children and young adults under 21 years of age.5 Enhanced surveillance identified 14 cases, including 4 deaths. Of these cases, 8 had evidence of encephalopathy and 1 had evidence of myocarditis. Most of the cases were caused by influenza A, although the H (hemagglutin) and N (neuraminidase) subtypes varied. Cases of influenza-associated acute encephalopathy among children have also been reported in Japan. These occurrences have prompted recommendations for further studies to better define the frequency of serious complications from influenza in children and young adults and to incorporate such findings into evaluations of current vaccine recommendations for children.5

Clinical management: Each year, about 9%–20% of healthy children aged less than 5 years will require health care for an influenza-related illness.6 Common presentations include a febrile illness, an acute respiratory tract illness and otitis media. Children less than 2 are most susceptible to the serious complications of influenza and may present with pneumonia, croup, bronchiolitis and sepsis.6 One cannot diagnose influenza virus infections clinically with confidence because many respiratory viruses (e.g., parainfluenza, respiratory syncytial virus, adenovirus and coxsackievirus) cause similar symptoms and signs.7 Rapid enzyme-linked immunosorbent assay and polymerase chain reaction diagnostic tests for influenza A and B are available but have not been widely used in the office setting, primarily because in most cases the disease is self-limiting and the treatment options for influenza infection in children are limited.

Amantidine syrup is available for treating influenza A in children and may also be used for chemoprophylaxis in unvaccinated contacts with underlying illness that puts them at high risk of severe infection. Neuraminidase inhibitors (e.g., oseltamivir and zanamivar) are active against influenza A and B and are often used in adults.7 Their role in young children has not been clearly established, although authors of a recent Cochrane review of the evidence concluded that they were effective in shortening illness duration in previously healthy children aged 1–12 years with a clinical or laboratory diagnosis of influenza and that efficacy in children with asthma remains to be proven.8

Prevention: The key to controlling influenza infection is prevention. The importance of hand-washing cannot be overemphasized. Vaccination works to prevent cases;9 one of the biggest factors influencing whether a child is vaccinated is whether the family physician recommends it (odds ratio 6.8, 95% confidence interval 2.4–19.2).10 The antigenic characteristics of current and emerging influenza virus strains provide the basis for selecting the strains included in each year's vaccine. Previously unvaccinated children less than 9 years old require 2 doses (4 weeks apart) of the split-virus influenza vaccine.2 Previously vaccinated children less than 9 years old do not require the second dose, nor do older children. The recommended single dose of vaccine is 0.25 mL for children aged 6–35 months and 0.50 mL for older children. Intramuscular administration is preferred. Newer vaccines, such as the cold-adapted, live attenuated vaccine administered as a large-droplet intranasal spray, are currently under review.11

Erica Weir CMAJ

References

  1. 1.↵
    Advisory Committee on Immunization Practices, US Centers for Disease Control and Prevention. Prevention and control of influenza: recommendation of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2002;51(RR-3):1-31.
    OpenUrlPubMed
  2. 2.↵
    National Advisory Committee on Immunization. Statement on influenza vaccination for the 2003–2004 season. Can Commun Dis Rep 2003; 29: 1-20.
    OpenUrlPubMed
  3. 3.↵
    Baltimore R, Jenson H. New recommendations for influenza vaccination for children and pregnant women. Curr Opin Pediatr 2003;15:74-6.
    OpenUrlPubMed
  4. 4.↵
    Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000;342:232-9.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Severe morbidity and mortality associated with influenza in children and young adults — Michigan, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:837-40.
    OpenUrlPubMed
  6. 6.↵
    Neuzil KM, Zhu Y, Griffin MR, Edwards KM, Thompson JM, Tollefson SJ, et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 2002;185:147-52. [Epub 2001 Dec 17.]
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    Stiver G. The treatment of influenza with antiviral drugs [review]. CMAJ 2003:168(1):49-57.
  8. 8.↵
    Matheson NJ, Symmonds-Abrahams M, Sheikh A, Shepperd S, Harnden A. Neuraminidase inhibitors for preventing and treating influenza in children. Cochrane Database Syst Rev 2003;(3):CD002744.
  9. 9.↵
    Hurwitz ES, Haber M, Chang A, Shope T, Teo S, Ginsberg M, et al. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA 2000;284:1677-82.
    OpenUrlCrossRefPubMed
  10. 10.↵
    Grant VJ, Le Saux N, Plint AC, Correll R, Gaboury I, Ellis E, et al. Factors influencing childhood influenza immunization. CMAJ 2003;168(1):39-41.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    Zangwill KM. Cold-adapted, live attenuated intranasal influenza virus vaccine [review]. Pediatr Infect Dis J 2003;22:273-4.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 169 (10)
CMAJ
Vol. 169, Issue 10
11 Nov 2003
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Influenza in children
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Influenza in children
Erica Weir
CMAJ Nov 2003, 169 (10) 1052;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Influenza in children
Erica Weir
CMAJ Nov 2003, 169 (10) 1052;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic
  • Google Scholar

More in this TOC Section

  • Seasonal drinking: Let's avoid the “January effect”
  • Latent tuberculosis: revised treatment guidelines
Show more Public Health

Similar Articles

Collections

  • Topics
    • Vaccination
    • Infectious diseases

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire